{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,11]],"date-time":"2025-12-11T20:37:00Z","timestamp":1765485420066,"version":"3.44.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,12,1]],"date-time":"2009-12-01T00:00:00Z","timestamp":1259625600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2009,12]]},"DOI":"10.1016\/j.metabol.2009.04.043","type":"journal-article","created":{"date-parts":[[2009,9,30]],"date-time":"2009-09-30T04:57:35Z","timestamp":1254286655000},"page":"1681-1687","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Clinical characteristics and efficacy of pioglitazone in a Japanese diabetic patient with an unusual type of familial partial lipodystrophy"],"prefix":"10.1016","volume":"58","author":[{"given":"Masanori","family":"Iwanishi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Ebihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toru","family":"Kusakabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Masuzaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiminori","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuwa","family":"Nakao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2009.04.043_bib1","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1056\/NEJMra025261","article-title":"Acquired and inherited lipodystrophies","volume":"350","author":"Garg","year":"2004","journal-title":"N Eng J Med"},{"key":"10.1016\/j.metabol.2009.04.043_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1146\/annurev.genom.7.080505.115715","article-title":"Genetic disorders of adipose tissue development, differentiation and death","volume":"7","author":"Agarwal","year":"2006","journal-title":"Annu Rev Genomics Hum Genet"},{"key":"10.1016\/j.metabol.2009.04.043_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1146\/annurev.med.57.022605.114424","article-title":"Genetic basis of lipodystrophies and management of metabolic complications","volume":"57","author":"Agarwal","year":"2006","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.metabol.2009.04.043_bib4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1210\/jc.2006-1546","article-title":"Efficacy and safety of leptin-replacement therapy and possible mechanisms of leptin actions in patients with generalized lipodystrophy","volume":"92","author":"Ebihara","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2009.04.043_bib5","first-page":"33","article-title":"Familial lipoatrophic diabetes with Dominant transmission","volume":"169","author":"Dunnigan","year":"1974","journal-title":"Q J Med"},{"key":"10.1016\/j.metabol.2009.04.043_bib6","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1006\/bbrc.1999.0255","article-title":"Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity","volume":"257","author":"Arita","year":"1999","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2009.04.043_bib7","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/diacare.23.8.1067","article-title":"Efficacy of troglitazone on body fat distribution type 2 diabetes","volume":"23","author":"Akazawa","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2009.04.043_bib8","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1086\/339274","article-title":"Homozygous defects in LMNA, encoding lamin A\/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot-Marie-Tooth disorder type 2) and mouse","volume":"70","author":"Sandre-Giovannoli","year":"2002","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.metabol.2009.04.043_bib9","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1006\/bbrc.1996.1044","article-title":"Molecular cloning, expression and characterization of Human peroxisome proliferator activated receptors r1 and r2","volume":"224","author":"Elbrecht","year":"1996","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2009.04.043_bib10","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1126\/science.1096706","article-title":"Family with severe insulin resistance and diabetes due to a mutation in AKT2","volume":"304","author":"George","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.metabol.2009.04.043_bib11","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1210\/jc.2007-1328","article-title":"Association of a homozygous nonsense caveolin-1 mutation with Berardinelli-Seip congenital lipodystrophy","volume":"93","author":"Kim","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2009.04.043_bib12","doi-asserted-by":"crossref","first-page":"5655","DOI":"10.1210\/jc.2004-0280","article-title":"A single-base mutation in the peroxisome proliferator\u2013activated receptor G4 promotor associated with altered in vitro expression and partial lipodystrophy","volume":"89","author":"Shali","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2009.04.043_bib13","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1210\/jcem.80.12.8530581","article-title":"An unusual type of familial lipodystrophy","volume":"80","author":"Johansen","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2009.04.043_bib14","doi-asserted-by":"crossref","first-page":"656","DOI":"10.4158\/EP.13.6.656","article-title":"Efficacy and safety of pioglitazone in treatment of a patient with an atypical lipodystrophy syndrome","volume":"13","author":"Sleilati","year":"2007","journal-title":"Endocri Pract"},{"key":"10.1016\/j.metabol.2009.04.043_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1476-511X-7-3","article-title":"Heterozygous CAVI frameshift mutation (MIM601047) in patients with atypical partial lipodystrophy and hypertriglyceridemia","volume":"7","author":"Cao","year":"2008","journal-title":"Lipids in Heath and Disease"},{"issue":"4","key":"10.1016\/j.metabol.2009.04.043_bib16","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1210\/jc.2008-0426","article-title":"Caveolin-1: a new locus for human lipodystrophy","volume":"93","author":"Garg","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2009.04.043_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","article-title":"LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy","volume":"24","author":"Shackleton","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/j.metabol.2009.04.043_bib18","doi-asserted-by":"crossref","first-page":"910","DOI":"10.2337\/diabetes.52.4.910","article-title":"Human metabolic syndrome resulting from dominant-negative mutations in the nuclear receptor peroxisome proliferator\u2013activated receptor\u2013G","volume":"52","author":"Savage","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2009.04.043_bib19","doi-asserted-by":"crossref","first-page":"3586","DOI":"10.2337\/diabetes.51.12.3586","article-title":"PPARG F388L, a transactivation-deficient mutant, in familial partial lipodystrophy","volume":"51","author":"Hegele","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2009.04.043_bib20","first-page":"408","article-title":"Novel heterozygous mutation in peroxisome proliferator\u2013activated receptor\u2013G gene in a patient with familial partial lipodystrophy","volume":"87","author":"Agarwal","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2009.04.043_bib21","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1073\/pnas.87.2.658","article-title":"A nonsense mutation causing decreased levels of insulin receptor mRNA: detection by a simplified technique for direct sequencing of genomic DNA amplified by the polymerase chain reaction","volume":"87","author":"Kadowaki","year":"1990","journal-title":"Proc.Natl.Acad.Sci.USA"},{"key":"10.1016\/j.metabol.2009.04.043_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-133-4-200008150-00009","article-title":"Efficacy and safety of troglitazone in the treatment of lipodystrophy syndromes","volume":"133","author":"Arioglu","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2009.04.043_bib23","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1046\/j.1464-5491.2003.01034.x","article-title":"Response to treatment with rosiglitazone in familial partial lipodystrophy due to a mutation in the LMNA gene","volume":"20","author":"Owen","year":"2003","journal-title":"Diabet. Med"},{"key":"10.1016\/j.metabol.2009.04.043_bib24","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1111\/j.1464-5491.2005.01757.x","article-title":"Long-term treatment experience in a subject with Dunnigan-type familial partial lipodystrophy: efficacy of rosiglitazone","volume":"22","author":"Ludtke","year":"2005","journal-title":"Diabet. Med"},{"key":"10.1016\/j.metabol.2009.04.043_bib25","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1210\/edrv.23.2.0461","article-title":"Disordered fat storage and mobilization in the pathogenesis of insulin resistance and type 2 diabetes","volume":"23","author":"Lewis","year":"2002","journal-title":"Endocrine Reviews"},{"key":"10.1016\/j.metabol.2009.04.043_bib26","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1016\/j.biochi.2003.10.010","article-title":"Central role of the adipocyte in the insulin-sensitising and cardiovascular risk modifying action of the thiazolidinediones","volume":"85","author":"Smith","year":"2003","journal-title":"Biochime"},{"key":"10.1016\/j.metabol.2009.04.043_bib27","first-page":"1776","article-title":"Gender differences in the prevalence of metabolic complications in familial partial lipodystrophy (Dunnigan variety)","volume":"85","author":"Garg","year":"2000","journal-title":"J Clin Endocrinol Metab"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049509001851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0026049509001851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T03:41:13Z","timestamp":1758426073000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0026049509001851"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2009,12]]}},"alternative-id":["S0026049509001851"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2009.04.043","relation":{},"ISSN":["0026-0495"],"issn-type":[{"type":"print","value":"0026-0495"}],"subject":[],"published":{"date-parts":[[2009,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical characteristics and efficacy of pioglitazone in a Japanese diabetic patient with an unusual type of familial partial lipodystrophy","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2009.04.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2009 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}